HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Champagne growers, shippers and producers v. YSL

This article was originally published in The Rose Sheet

Executive Summary

Comite Interprofessional du Vin de Champagne (CIVC), an association of French champagne growers and shippers, and l'Institut National des Apellations d'Origine (AINO), a group that works to protect the exclusivity of the appellations or origin on French wines file a lawsuit in Belgium attempting to bar Yves Saint Laurent from using the Champagne name on its recently launched women's fragrance. The action is the fourth suit filed by the groups since the fragrance debuted in Europe, Africa and the Middle East last September. CIVC and AINO have succeeded in forcing YSL to cease use of the name in France ("The Rose Sheet" Dec. 20, p. 9) and have suits pending in England and Germany. A decision is expected in Germany in October; no trial date has been set in England

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000627

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel